Literature DB >> 3443065

Renal effects of felodipine in hypertension.

G Leonetti1, L Terzoli, L Rupoli, R Gradnik, A Zanchetti.   

Abstract

The results of 2 recent studies on the renal effects of felodipine in hypertensive patients are described. Antihypertensive doses of felodipine (10mg bid) displayed a clear natriuretic and diuretic effect associated with a constant glomerular filtration rate and an increase in renal plasma flow. With higher doses of felodipine (up to 50mg tid), the natriuretic effect was reversed to an antinatriuretic effect, accompanied by a reduction in glomerular filtration rate. The natriuretic effect of felodipine 10mg bid was evident during the first 2 days of administration, but a negative sodium balance was still present at the end of the seventh day. The mechanisms of the renal effects of calcium antagonists are discussed as well as the relevance of the natriuretic effect for the antihypertensive action of these compounds.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3443065     DOI: 10.2165/00003495-198700343-00013

Source DB:  PubMed          Journal:  Drugs        ISSN: 0012-6667            Impact factor:   9.546


  9 in total

1.  Adrenergic sodium handling and the natriuretic action of calcium antagonists.

Authors:  A Zanchetti; A Stella; R Golin
Journal:  J Cardiovasc Pharmacol       Date:  1985       Impact factor: 3.105

2.  Effects of single and repeated doses of the calcium antagonist felodipine on blood pressure, renal function, electrolytes and water balance, and renin-angiotensin-aldosterone system in hypertensive patients.

Authors:  G Leonetti; R Gradnik; L Terzoli; M Fruscio; L Rupoli; C Cuspidi; L Sampieri; A Zanchetti
Journal:  J Cardiovasc Pharmacol       Date:  1986 Nov-Dec       Impact factor: 3.105

Review 3.  Discussion on the natriuretic effect of calcium antagonists.

Authors:  A Zanchetti; G Leonetti
Journal:  J Cardiovasc Pharmacol       Date:  1987       Impact factor: 3.105

4.  Antihypertensive and renal effects of orally administered verapamil.

Authors:  G Leonetti; C Sala; C Bianchini; L Terzoli; A Zanchetti
Journal:  Eur J Clin Pharmacol       Date:  1980-11       Impact factor: 2.953

Review 5.  Natriuretic effect of calcium antagonists.

Authors:  A Zanchetti; G Leonetti
Journal:  J Cardiovasc Pharmacol       Date:  1985       Impact factor: 3.105

6.  Renal tubular site of action of felodipine.

Authors:  G F Dibona; L L Sawin
Journal:  J Pharmacol Exp Ther       Date:  1984-02       Impact factor: 4.030

7.  Renal and antihypertensive effects of felodipine in hypertensive patients.

Authors:  G Leonetti; R Gradnik; L Terzoli; M Fruscio; L Rupoli; C Cuspidi; L Sampieri; A Zanchetti
Journal:  J Hypertens Suppl       Date:  1985-12

8.  Factors influencing the hypotensive effects of calcium antagonists.

Authors:  P Erne; P Bolli; O Bertel; U L Hulthen; W Kiowski; F B Muller; F Buhler
Journal:  Hypertension       Date:  1983 Jul-Aug       Impact factor: 10.190

9.  Felodipine, a new vasodilating drug: blood pressure, cardiac, renal, and humoral effects in hypertensive patients.

Authors:  G Leonetti; R Gradnik; L Terzoli; M Fruscio; L Rupoli; A Zanchetti
Journal:  J Cardiovasc Pharmacol       Date:  1984 May-Jun       Impact factor: 3.105

  9 in total
  9 in total

Review 1.  Rationale for the use of a fixed-dose combination in the management of hypertension: efficacy and tolerability of lercanidipine/enalapril.

Authors:  Claudio Borghi; Arrigo F G Cicero
Journal:  Clin Drug Investig       Date:  2010       Impact factor: 2.859

Review 2.  Fixed-dose combination antihypertensive drugs. Do they have a role in rational therapy?

Authors:  D A Sica
Journal:  Drugs       Date:  1994-07       Impact factor: 9.546

3.  Ambulatory blood pressure monitoring during sustained treatment with conventional and extended-release felodipine in mild-to-moderate hypertension.

Authors:  C Porcellati; P Verdecchia; C Gatteschi; G Benemio; M Guerrieri; F Boldrini; G Pollavini
Journal:  Eur J Clin Pharmacol       Date:  1989       Impact factor: 2.953

Review 4.  Rationale for fixed-dose combinations in the treatment of hypertension: the cycle repeats.

Authors:  Domenic A Sica
Journal:  Drugs       Date:  2002       Impact factor: 9.546

5.  Antihypertensive and biochemical effects of the dihydropyridine felodipine in the long term treatment of moderate to severe hypertension.

Authors:  H E Sluiter; F T Huysman; T A Thien; R A Koene
Journal:  Drugs       Date:  1987       Impact factor: 9.546

Review 6.  Felodipine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in hypertension.

Authors:  E Saltiel; A G Ellrodt; J P Monk; M S Langley
Journal:  Drugs       Date:  1988-10       Impact factor: 9.546

7.  The acute haemodynamic and renal effects of oral felodipine and ramipril in healthy subjects.

Authors:  B Hasselgren; B Edgar; G Johnsson; O Rönn
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

8.  Felodipine in combination with a beta-blocker and a diuretic in chronic treatment of patients with refractory primary hypertension.

Authors:  O K Andersson; T Hedner; G Granérus
Journal:  Drugs       Date:  1987       Impact factor: 9.546

9.  Calcium-channel blockers and sodium intake: a controlled study in patients with essential hypertension.

Authors:  F Galletti; P Strazzullo; F P Cappuccio; G Barba; N Giorgione; R Gagliardi; M Mancini
Journal:  Cardiovasc Drugs Ther       Date:  1989-04       Impact factor: 3.727

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.